The wholly-owned US subsidiary grows and manufactures and distributes hemp products to about 40 countries.
The Oz hemp revenue comes from local growing and manufacturing.
The Oz medical cannabis subsidiary is not yet in production, but could become a significant contributor to earnings.
This is a well-established hemp company with significant growth (pun intended) already underway.
Ann: Quarterly Report and Appendix 4C, page-17
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.002(33.3%) |
Mkt cap ! $6.605M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $2.103K | 475.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 7670493 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 924824 | 4 |
View Market Depth
| Last trade - 14.04pm 29/11/2024 (20 minute delay) ? |
| EXL (ASX) Chart |
